| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 421.198 | 90 |
| GSM780708 | Untreated after 4 days (C2_1) | 396.636 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 483.814 | 91 |
| GSM780719 | Untreated after 4 days (C1_2) | 406.008 | 90 |
| GSM780720 | Untreated after 4 days (C2_2) | 441.736 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 476.007 | 91 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 400.583 | 90 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 427.84 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 368.936 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 346.103 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 418.301 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 362.142 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 437.747 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 411.192 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 481.827 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 474.812 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 449.392 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 427.377 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 454.506 | 91 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 410.37 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 439.434 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 429.361 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 417.305 | 90 |